Taiwan FDA registration 63e62f722cee5d9eb48a8d8ab0a5cbc9
Baide fenwal glycerol solution
TW: 佰德 芬沃甘油溶液
Taiwan·Risk Class 1·BAXTER HEALTHCARE CORPORATION·Registered May 19, 2009 – May 19, 2014CancelledRegistration details
- Analysis ID
- 63e62f722cee5d9eb48a8d8ab0a5cbc9
- Customs Code
- DHA04400774003
Company information
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- Y.H. BIOTEK CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9225 Cell freezing equipment and reagents for in vitro diagnostics
- Import Information
- import
Dates and status
- Registration Date
- May 19, 2009
- Expiry Date
- May 19, 2014
- Cancellation Date
- Jan 09, 2017
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Baide fenwal glycerol solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 63e62f722cee5d9eb48a8d8ab0a5cbc9 and manufactured by BAXTER HEALTHCARE CORPORATION. The authorized representative in Taiwan is Y.H. BIOTEK CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices